Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Mental Disease

PUBLISHER: KBV Research | PRODUCT CODE: 1126871

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1126871

Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product, By Regional Outlook and Forecast, 2022 - 2028

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 3600
PDF (Site License)
USD 4320
PDF (Enterprisewide License)
USD 6048

Add to Cart

Description

Table of Contents

List of Tables

The Global Narcolepsy Therapeutics Market size is expected to reach $5 billion by 2028, rising at a market growth of 10.5% CAGR during the forecast period.

Chronic, incapacitating neurologic disease called narcolepsy is characterized by excessive daytime sleepiness (EDS). Modafinil, armodafinil, and stimulants are only a few of the medications used to treat narcolepsy. Others include sodium oxybate and venlafaxine, which are used to treat the symptoms of sleep paralysis and sleep-related hallucinations (e.g. sodium oxybate).

In general, drugs that boost norepinephrine or dopamine release or prevent their reuptake have wake-promoting effects and can help manage EDS, whereas drugs that block serotonin or norepinephrine reuptake have anti-cataplexy benefits. Both EDS and cataplexy are affected by the modification of either histamine H3 receptors (H3Rs) or -aminobutyric acid B (GABAB) receptors.

The most recent approved medications for EDS related to narcolepsy in the European Union and the USA are solriamfetol, a dopamine and norepinephrine reuptake inhibitor, and pitolisant, an H3R antagonist. Many new drugs are being developed and tested as potential treatments for EDS and cataplexy associated with narcolepsy (THN102), including novel Oxybate formulations of low sodium [FT218] and one-nightly [JZP-258], selective norepinephrine reuptake inhibitors (AXS-12), and modafinil and astroglial connexin inhibitors (THN102).

The mechanisms of action, pharmacokinetics, effectiveness, and safety/tolerability of recently authorized and developing therapies for narcolepsy. A chronic, incapacitating neurologic condition of hypersomnolence called narcolepsy is thought to affect 20-67 persons per 100,000 people across the world. Narcolepsy typically begins in the second decade of life; however, a diagnosis is frequently made much later.

Excessive daytime sleepiness (EDS), while not a specific symptom of narcolepsy, is a feature of the illness that must be present in all individuals to make the diagnosis. Up to 60% of patients have cataplexy, an involuntary decrease of muscle tone while awake that is generally brought on by intense emotions. Restless nights, hypnagogic and hypnopompic hallucinations that happen when the user falls asleep and wakes up, and sleep paralysis are other symptoms.

COVID-19 Impact Analysis

During the pandemic, COVID-19 had a detrimental effect on narcolepsy medications. The biggest problem is that patients with narcolepsy can stop taking their medication because they are unable to get their prescriptions filled because of transportation limitations, home quarantines, and hospital cross-infection fears. Additionally, because there is no effective treatment for COVID-19, manufacturers and companies are concentrating more on producing the pharmaceuticals and tools that are required for treating COVID-19.  

Market Growth Factors

Growing Healthcare Expenditures

One of the main factors boosting the market's rise is the rising number and size of investments made in the healthcare sector by governments of various countries. It is anticipated that more developing nations would have greater access to high-quality healthcare as a result of their quick economic development and growing healthcare costs. This is viewed as a positive indicator of expansion for the narcolepsy therapeutics industry. The need for various treatment and apparatus has surged in these nations due to the rising insomnia problems.

Increasing Prevalence Of Neurological Conditions

Neurologists treat a wide variety of sleep problems, including narcolepsy, sleep apnea, restless legs syndrome, insomnia, and sleep apnea. Endogenous irregularities are brought on by several illnesses, which interfere with the regular sleep-wake cycle. In the upcoming years, neurological sleep-related diseases are predicted to rise as a significant section of the population ages. The National Institute of Health (NIH) estimates that 20 million Americans occasionally have sleep issues, whereas 40 million Americans suffer from neurological illnesses.

Market Restraining Factors

High Cost Of Narcolepsy Diagnosis & Treatment

One of the main factors holding back the narcolepsy market is the high cost of narcolepsy diagnosis and treatment. Additionally, the term "sleeping problem" refers to a broad range of illnesses with serious negative effects on the health of the individual and huge societal costs. Furthermore, in 2019 the smooth operation of the narcolepsy market is disrupted by the high cost of therapy. Daily functioning is hampered by narcolepsy, which is also connected with a significant financial and medical burden-many patients are fully disabled.

Type Outlook

On the basis of Type, the Narcolepsy Therapeutics Market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy. The Narcolepsy with Cataplexy segment acquired the highest revenue share in the narcolepsy therapeutics market in 2021. It is because cataplexy is becoming a more common significant symptom among patients. Throughout the prediction, it is anticipated to hold onto its position.

Product Outlook

Based on the Product, the Narcolepsy Therapeutics Market is divided into Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake inhibitors, Tricyclic Antidepressants, and Others. The Central Nervous System Stimulants segment recorded a substantial revenue share in the narcolepsy therapeutics market in 2021. It is because the data analysis of CNS Drugs assesses the time to onset of response to pitolisant for excessive daytime sleepiness (EDS) and cataplexy in adult narcolepsy patients.

Regional Outlook

Region-wise, the Narcolepsy Therapeutics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region garnered a promising revenue share in the narcolepsy therapeutics market in 2021. It is due to economic growth, a rise in public awareness, high levels of disposable money, a rise in investments in the pharmaceutical and biotechnology industries, and benevolent government efforts. Among the Asia Pacific nations, Japan has been noted as having a high prevalence of narcolepsy.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Jazz Pharmaceuticals plc, Shionogi & Co., Ltd., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc. (Arena Pharmaceuticals, Inc.), Bioprojet, Takeda Pharmaceutical Company Limited, Ligand Pharmaceuticals, Inc., and Graymark Healthcare, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Narcolepsy with Cataplexy
  • Narcolepsy Without Cataplexy
  • Secondary Narcolepsy

By Product

  • Sodium Oxybate
  • Selective Serotonin Reuptake Inhibitor
  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Jazz Pharmaceuticals plc
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
  • Bioprojet
  • Takeda Pharmaceutical Company Limited
  • Ligand Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Show more

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Narcolepsy Therapeutics Market, by Type
    • 1.4.2 Global Narcolepsy Therapeutics Market, by Product
    • 1.4.3 Global Narcolepsy Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Narcolepsy Therapeutics Market by Type

  • 3.1 Global Narcolepsy with Cataplexy Market by Region
  • 3.2 Global Narcolepsy Without Cataplexy Market by Region
  • 3.3 Global Secondary Narcolepsy Market by Region

Chapter 4. Global Narcolepsy Therapeutics Market by Product

  • 4.1 Global Sodium Oxybate Market by Region
  • 4.2 Global Selective Serotonin Reuptake Inhibitor Market by Region
  • 4.3 Global Central Nervous System Stimulants Market by Region
  • 4.4 Global Tricyclic Antidepressants Market by Region
  • 4.5 Global Others Market by Region

Chapter 5. Global Narcolepsy Therapeutics Market by Region

  • 5.1 North America Narcolepsy Therapeutics Market
    • 5.1.1 North America Narcolepsy Therapeutics Market by Type
      • 5.1.1.1 North America Narcolepsy with Cataplexy Market by Country
      • 5.1.1.2 North America Narcolepsy Without Cataplexy Market by Country
      • 5.1.1.3 North America Secondary Narcolepsy Market by Country
    • 5.1.2 North America Narcolepsy Therapeutics Market by Product
      • 5.1.2.1 North America Sodium Oxybate Market by Country
      • 5.1.2.2 North America Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.1.2.3 North America Central Nervous System Stimulants Market by Country
      • 5.1.2.4 North America Tricyclic Antidepressants Market by Country
      • 5.1.2.5 North America Others Market by Country
    • 5.1.3 North America Narcolepsy Therapeutics Market by Country
      • 5.1.3.1 US Narcolepsy Therapeutics Market
        • 5.1.3.1.1 US Narcolepsy Therapeutics Market by Type
        • 5.1.3.1.2 US Narcolepsy Therapeutics Market by Product
      • 5.1.3.2 Canada Narcolepsy Therapeutics Market
        • 5.1.3.2.1 Canada Narcolepsy Therapeutics Market by Type
        • 5.1.3.2.2 Canada Narcolepsy Therapeutics Market by Product
      • 5.1.3.3 Mexico Narcolepsy Therapeutics Market
        • 5.1.3.3.1 Mexico Narcolepsy Therapeutics Market by Type
        • 5.1.3.3.2 Mexico Narcolepsy Therapeutics Market by Product
      • 5.1.3.4 Rest of North America Narcolepsy Therapeutics Market
        • 5.1.3.4.1 Rest of North America Narcolepsy Therapeutics Market by Type
        • 5.1.3.4.2 Rest of North America Narcolepsy Therapeutics Market by Product
  • 5.2 Europe Narcolepsy Therapeutics Market
    • 5.2.1 Europe Narcolepsy Therapeutics Market by Type
      • 5.2.1.1 Europe Narcolepsy with Cataplexy Market by Country
      • 5.2.1.2 Europe Narcolepsy Without Cataplexy Market by Country
      • 5.2.1.3 Europe Secondary Narcolepsy Market by Country
    • 5.2.2 Europe Narcolepsy Therapeutics Market by Product
      • 5.2.2.1 Europe Sodium Oxybate Market by Country
      • 5.2.2.2 Europe Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.2.2.3 Europe Central Nervous System Stimulants Market by Country
      • 5.2.2.4 Europe Tricyclic Antidepressants Market by Country
      • 5.2.2.5 Europe Others Market by Country
    • 5.2.3 Europe Narcolepsy Therapeutics Market by Country
      • 5.2.3.1 Germany Narcolepsy Therapeutics Market
        • 5.2.3.1.1 Germany Narcolepsy Therapeutics Market by Type
        • 5.2.3.1.2 Germany Narcolepsy Therapeutics Market by Product
      • 5.2.3.2 UK Narcolepsy Therapeutics Market
        • 5.2.3.2.1 UK Narcolepsy Therapeutics Market by Type
        • 5.2.3.2.2 UK Narcolepsy Therapeutics Market by Product
      • 5.2.3.3 France Narcolepsy Therapeutics Market
        • 5.2.3.3.1 France Narcolepsy Therapeutics Market by Type
        • 5.2.3.3.2 France Narcolepsy Therapeutics Market by Product
      • 5.2.3.4 Russia Narcolepsy Therapeutics Market
        • 5.2.3.4.1 Russia Narcolepsy Therapeutics Market by Type
        • 5.2.3.4.2 Russia Narcolepsy Therapeutics Market by Product
      • 5.2.3.5 Spain Narcolepsy Therapeutics Market
        • 5.2.3.5.1 Spain Narcolepsy Therapeutics Market by Type
        • 5.2.3.5.2 Spain Narcolepsy Therapeutics Market by Product
      • 5.2.3.6 Italy Narcolepsy Therapeutics Market
        • 5.2.3.6.1 Italy Narcolepsy Therapeutics Market by Type
        • 5.2.3.6.2 Italy Narcolepsy Therapeutics Market by Product
      • 5.2.3.7 Rest of Europe Narcolepsy Therapeutics Market
        • 5.2.3.7.1 Rest of Europe Narcolepsy Therapeutics Market by Type
        • 5.2.3.7.2 Rest of Europe Narcolepsy Therapeutics Market by Product
  • 5.3 Asia Pacific Narcolepsy Therapeutics Market
    • 5.3.1 Asia Pacific Narcolepsy Therapeutics Market by Type
      • 5.3.1.1 Asia Pacific Narcolepsy with Cataplexy Market by Country
      • 5.3.1.2 Asia Pacific Narcolepsy Without Cataplexy Market by Country
      • 5.3.1.3 Asia Pacific Secondary Narcolepsy Market by Country
    • 5.3.2 Asia Pacific Narcolepsy Therapeutics Market by Product
      • 5.3.2.1 Asia Pacific Sodium Oxybate Market by Country
      • 5.3.2.2 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.3.2.3 Asia Pacific Central Nervous System Stimulants Market by Country
      • 5.3.2.4 Asia Pacific Tricyclic Antidepressants Market by Country
      • 5.3.2.5 Asia Pacific Others Market by Country
    • 5.3.3 Asia Pacific Narcolepsy Therapeutics Market by Country
      • 5.3.3.1 China Narcolepsy Therapeutics Market
        • 5.3.3.1.1 China Narcolepsy Therapeutics Market by Type
        • 5.3.3.1.2 China Narcolepsy Therapeutics Market by Product
      • 5.3.3.2 Japan Narcolepsy Therapeutics Market
        • 5.3.3.2.1 Japan Narcolepsy Therapeutics Market by Type
        • 5.3.3.2.2 Japan Narcolepsy Therapeutics Market by Product
      • 5.3.3.3 India Narcolepsy Therapeutics Market
        • 5.3.3.3.1 India Narcolepsy Therapeutics Market by Type
        • 5.3.3.3.2 India Narcolepsy Therapeutics Market by Product
      • 5.3.3.4 South Korea Narcolepsy Therapeutics Market
        • 5.3.3.4.1 South Korea Narcolepsy Therapeutics Market by Type
        • 5.3.3.4.2 South Korea Narcolepsy Therapeutics Market by Product
      • 5.3.3.5 Singapore Narcolepsy Therapeutics Market
        • 5.3.3.5.1 Singapore Narcolepsy Therapeutics Market by Type
        • 5.3.3.5.2 Singapore Narcolepsy Therapeutics Market by Product
      • 5.3.3.6 Malaysia Narcolepsy Therapeutics Market
        • 5.3.3.6.1 Malaysia Narcolepsy Therapeutics Market by Type
        • 5.3.3.6.2 Malaysia Narcolepsy Therapeutics Market by Product
      • 5.3.3.7 Rest of Asia Pacific Narcolepsy Therapeutics Market
        • 5.3.3.7.1 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type
        • 5.3.3.7.2 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product
  • 5.4 LAMEA Narcolepsy Therapeutics Market
    • 5.4.1 LAMEA Narcolepsy Therapeutics Market by Type
      • 5.4.1.1 LAMEA Narcolepsy with Cataplexy Market by Country
      • 5.4.1.2 LAMEA Narcolepsy Without Cataplexy Market by Country
      • 5.4.1.3 LAMEA Secondary Narcolepsy Market by Country
    • 5.4.2 LAMEA Narcolepsy Therapeutics Market by Product
      • 5.4.2.1 LAMEA Sodium Oxybate Market by Country
      • 5.4.2.2 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.4.2.3 LAMEA Central Nervous System Stimulants Market by Country
      • 5.4.2.4 LAMEA Tricyclic Antidepressants Market by Country
      • 5.4.2.5 LAMEA Others Market by Country
    • 5.4.3 LAMEA Narcolepsy Therapeutics Market by Country
      • 5.4.3.1 Brazil Narcolepsy Therapeutics Market
        • 5.4.3.1.1 Brazil Narcolepsy Therapeutics Market by Type
        • 5.4.3.1.2 Brazil Narcolepsy Therapeutics Market by Product
      • 5.4.3.2 Argentina Narcolepsy Therapeutics Market
        • 5.4.3.2.1 Argentina Narcolepsy Therapeutics Market by Type
        • 5.4.3.2.2 Argentina Narcolepsy Therapeutics Market by Product
      • 5.4.3.3 UAE Narcolepsy Therapeutics Market
        • 5.4.3.3.1 UAE Narcolepsy Therapeutics Market by Type
        • 5.4.3.3.2 UAE Narcolepsy Therapeutics Market by Product
      • 5.4.3.4 Saudi Arabia Narcolepsy Therapeutics Market
        • 5.4.3.4.1 Saudi Arabia Narcolepsy Therapeutics Market by Type
        • 5.4.3.4.2 Saudi Arabia Narcolepsy Therapeutics Market by Product
      • 5.4.3.5 South Africa Narcolepsy Therapeutics Market
        • 5.4.3.5.1 South Africa Narcolepsy Therapeutics Market by Type
        • 5.4.3.5.2 South Africa Narcolepsy Therapeutics Market by Product
      • 5.4.3.6 Nigeria Narcolepsy Therapeutics Market
        • 5.4.3.6.1 Nigeria Narcolepsy Therapeutics Market by Type
        • 5.4.3.6.2 Nigeria Narcolepsy Therapeutics Market by Product
      • 5.4.3.7 Rest of LAMEA Narcolepsy Therapeutics Market
        • 5.4.3.7.1 Rest of LAMEA Narcolepsy Therapeutics Market by Type
        • 5.4.3.7.2 Rest of LAMEA Narcolepsy Therapeutics Market by Product

Chapter 6. Company Profiles

  • 6.1 Jazz Pharmaceuticals plc
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Regional Analysis
    • 6.1.4 Research & Development Expenses
    • 6.1.5 Recent strategies and developments:
      • 6.1.5.1 Partnerships, Collaborations, and Agreements:
      • 6.1.5.2 Approvals and Trials:
  • 6.2 Shionogi & Co., Ltd.
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Research & Development Expenses
  • 6.3 Teva Pharmaceutical Industries Ltd.
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Regional Analysis
    • 6.3.4 Research & Development Expenses
  • 6.4 Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Regional & Segmental Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 Bioprojet
    • 6.5.1 Company Overview
    • 6.5.2 Recent strategies and developments:
      • 6.5.2.1 Partnerships, Collaborations, and Agreements:
  • 6.6 Takeda Pharmaceutical Company Limited
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Regional Analysis
    • 6.6.4 Research & Development Expense
  • 6.7 Ligand Pharmaceuticals, Inc.
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Research & Development Expenses
  • 6.8 Graymark Healthcare, Inc.
    • 6.8.1 Company Overview
Show more

LIST OF TABLES

  • TABLE 1 Global Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 2 Global Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 3 Global Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 4 Global Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 5 Global Narcolepsy with Cataplexy Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Narcolepsy with Cataplexy Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Narcolepsy Without Cataplexy Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Narcolepsy Without Cataplexy Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Secondary Narcolepsy Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Secondary Narcolepsy Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 12 Global Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 13 Global Sodium Oxybate Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Sodium Oxybate Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Selective Serotonin Reuptake Inhibitor Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Selective Serotonin Reuptake Inhibitor Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Central Nervous System Stimulants Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Central Nervous System Stimulants Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Tricyclic Antidepressants Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Tricyclic Antidepressants Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Narcolepsy Therapeutics Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Narcolepsy Therapeutics Market by Region, 2022 - 2028, USD Million
  • TABLE 25 North America Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 26 North America Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 27 North America Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 28 North America Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 29 North America Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 30 North America Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 31 North America Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 36 North America Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 37 North America Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 49 US Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 50 US Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 51 US Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 52 US Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 53 US Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 54 US Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 55 Canada Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 56 Canada Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 57 Canada Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 58 Canada Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 59 Canada Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 60 Canada Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 61 Mexico Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 62 Mexico Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 63 Mexico Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 64 Mexico Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 65 Mexico Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 66 Mexico Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 67 Rest of North America Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 68 Rest of North America Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 69 Rest of North America Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 70 Rest of North America Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 71 Rest of North America Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 72 Rest of North America Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 73 Europe Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 74 Europe Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 75 Europe Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 76 Europe Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 77 Europe Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Europe Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 80 Europe Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 81 Europe Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 82 Europe Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 83 Europe Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 84 Europe Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 85 Europe Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 86 Europe Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 87 Europe Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 88 Europe Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 89 Europe Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 90 Europe Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 91 Europe Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 92 Europe Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 93 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Germany Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 98 Germany Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 99 Germany Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 100 Germany Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 101 Germany Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 102 Germany Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 103 UK Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 104 UK Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 105 UK Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 106 UK Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 107 UK Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 108 UK Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 109 France Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 110 France Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 111 France Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 112 France Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 113 France Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 114 France Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 115 Russia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 116 Russia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 117 Russia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 118 Russia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 119 Russia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 120 Russia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 121 Spain Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 122 Spain Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 123 Spain Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 124 Spain Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 125 Spain Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 126 Spain Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 127 Italy Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 128 Italy Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 129 Italy Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 130 Italy Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 131 Italy Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 132 Italy Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 133 Rest of Europe Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 134 Rest of Europe Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 135 Rest of Europe Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 136 Rest of Europe Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 137 Rest of Europe Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 138 Rest of Europe Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 139 Asia Pacific Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 140 Asia Pacific Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 141 Asia Pacific Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 142 Asia Pacific Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 143 Asia Pacific Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 144 Asia Pacific Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 145 Asia Pacific Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 146 Asia Pacific Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 147 Asia Pacific Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 148 Asia Pacific Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 149 Asia Pacific Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 150 Asia Pacific Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 151 Asia Pacific Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 152 Asia Pacific Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 153 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 154 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 155 Asia Pacific Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 156 Asia Pacific Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 157 Asia Pacific Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 158 Asia Pacific Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 159 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 160 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 161 Asia Pacific Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 162 Asia Pacific Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 163 China Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 164 China Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 165 China Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 166 China Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 167 China Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 168 China Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 169 Japan Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 170 Japan Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 171 Japan Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 172 Japan Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 173 Japan Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 174 Japan Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 175 India Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 176 India Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 177 India Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 178 India Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 179 India Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 180 India Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 181 South Korea Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 182 South Korea Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 183 South Korea Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 184 South Korea Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 185 South Korea Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 186 South Korea Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 187 Singapore Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 188 Singapore Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 189 Singapore Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 190 Singapore Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 191 Singapore Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 192 Singapore Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 193 Malaysia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 194 Malaysia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 195 Malaysia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 196 Malaysia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 197 Malaysia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 198 Malaysia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 199 Rest of Asia Pacific Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 200 Rest of Asia Pacific Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 201 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 202 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 203 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 204 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 205 LAMEA Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 206 LAMEA Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 207 LAMEA Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 208 LAMEA Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 209 LAMEA Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 210 LAMEA Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 211 LAMEA Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 212 LAMEA Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 213 LAMEA Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 214 LAMEA Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 215 LAMEA Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 216 LAMEA Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 217 LAMEA Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 218 LAMEA Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 219 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 220 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 221 LAMEA Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 222 LAMEA Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 223 LAMEA Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 224 LAMEA Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 225 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 226 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 227 LAMEA Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 228 LAMEA Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 229 Brazil Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 230 Brazil Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 231 Brazil Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 232 Brazil Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 233 Brazil Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 234 Brazil Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 235 Argentina Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 236 Argentina Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 237 Argentina Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 238 Argentina Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 239 Argentina Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 240 Argentina Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 241 UAE Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 242 UAE Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 243 UAE Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 244 UAE Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 245 UAE Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 246 UAE Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 247 Saudi Arabia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 248 Saudi Arabia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 249 Saudi Arabia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 250 Saudi Arabia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 251 Saudi Arabia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 252 Saudi Arabia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 253 South Africa Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 254 South Africa Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 255 South Africa Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 256 South Africa Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 257 South Africa Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 258 South Africa Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 259 Nigeria Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 260 Nigeria Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 261 Nigeria Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 262 Nigeria Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 263 Nigeria Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 264 Nigeria Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 265 Rest of LAMEA Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 266 Rest of LAMEA Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 267 Rest of LAMEA Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 268 Rest of LAMEA Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 269 Rest of LAMEA Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 270 Rest of LAMEA Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 271 Key Information - Jazz Pharmaceuticals plc
  • TABLE 272 Key Information - Shionogi & Co., Ltd.
  • TABLE 273 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 274 Key Information - Pfizer, Inc.
  • TABLE 275 Key Information - Bioprojet
  • TABLE 276 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 277 Key Information - Ligand Pharmaceuticals, Inc.
  • TABLE 278 Key Information - Graymark Healthcare, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Narcolepsy Therapeutics Market Share by Type, 2021
  • FIG 3 Global Narcolepsy Therapeutics Market Share by Type, 2028
  • FIG 4 Global Narcolepsy Therapeutics Market by Type, 2018 - 2028, USD Million
  • FIG 5 Global Narcolepsy Therapeutics Market Share by Product, 2021
  • FIG 6 Global Narcolepsy Therapeutics Market Share by Product, 2028
  • FIG 7 Global Narcolepsy Therapeutics Market by Product, 2018 - 2028, USD Million
  • FIG 8 Global Narcolepsy Therapeutics Market Share by Region, 2021
  • FIG 9 Global Narcolepsy Therapeutics Market Share by Region, 2028
  • FIG 10 Global Narcolepsy Therapeutics Market by Region, 2018 - 2028, USD Million
  • FIG 11 Recent strategies and developments: Jazz Pharmaceuticals PLC
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!